Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Anxo Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,007	1,336	2,708	1,426	1,185	1,376
Market Cap Growth	-50.67%	-50.67%	89.95%	20.32%	-13.90%	-3.90%
Enterprise Value	1,490	1,837	3,497	2,194	1,989	2,164
Last Close Price	18.05	24.00	48.11	28.23	23.46	27.25
PE Ratio	-	-	123.88	-	61.60	43.82
PS Ratio	1.13	1.49	2.88	1.65	1.44	1.59
PB Ratio	0.88	1.17	2.25	1.72	1.42	1.70
P/TBV Ratio	1.03	1.37	2.58	2.09	1.71	2.05
P/FCF Ratio	14.47	19.18	-	25.16	27.23	31.35
P/OCF Ratio	9.00	11.93	-	20.00	15.12	22.98
EV/Sales Ratio	1.66	2.05	3.72	2.53	2.41	2.50
EV/EBITDA Ratio	78.19	448.02	30.92	32.01	19.10	17.14
EV/EBIT Ratio	-	-	65.59	368.98	49.61	37.97
EV/FCF Ratio	21.40	26.38	-	38.71	45.73	49.29
Debt / Equity Ratio	0.64	0.64	0.66	1.07	1.06	1.10
Debt / EBITDA Ratio	38.13	38.13	6.21	11.18	7.74	6.52
Debt / FCF Ratio	10.44	10.44	-	15.65	20.28	20.25
Asset Turnover	0.41	0.41	0.45	0.45	0.43	0.45
Inventory Turnover	2.09	2.09	2.06	2.22	1.95	2.13
Quick Ratio	1.15	1.15	1.33	0.89	0.92	0.88
Current Ratio	1.75	1.75	2.01	1.39	1.49	1.51
Return on Equity (ROE)	-4.62%	-4.62%	3.03%	-0.85%	2.40%	5.15%
Return on Assets (ROA)	-1.64%	-1.64%	1.59%	0.19%	1.31%	1.86%
Return on Capital (ROIC)	-1.83%	-1.83%	1.80%	0.22%	1.47%	2.11%
Return on Capital Employed (ROCE)	-	-	3.10%	0.40%	2.80%	3.90%
Earnings Yield	-5.68%	-4.28%	0.81%	-0.88%	1.62%	2.28%
FCF Yield	6.91%	5.21%	-2.23%	3.98%	3.67%	3.19%
Dividend Yield	2.23%	-	0.83%	-	-	-
Payout Ratio	-	-	-	-	-	36.52%
Buyback Yield / Dilution	-12.23%	-8.00%	-7.11%	0.66%	-0.88%	-7.05%
Total Shareholder Return	-10.00%	-8.00%	-6.28%	0.66%	-0.88%	-7.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.